other material
confidence high
sentiment neutral
materiality 0.45
Eton cancels $13.1M equity raise and credit expansion after losing Eiger auction
Eton Pharmaceuticals, Inc.
- Planned to issue 1,287,500 common shares at $3.50 and pre-funded warrants for 2,462,500 shares.
- Also planned to expand credit facility from $21.9M to $27.0M with a lender warrant for 358,976 shares.
- All transactions were contingent on winning an auction for Eiger BioPharmaceuticals assets on April 17, 2024.
- Eton was not the successful bidder; therefore all agreements were cancelled and are void.
- No underwriters were used; the offerings were exempt under Regulation D Rule 506.